BRPI0514630B8 - compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas - Google Patents
compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticasInfo
- Publication number
- BRPI0514630B8 BRPI0514630B8 BRPI0514630A BRPI0514630A BRPI0514630B8 BR PI0514630 B8 BRPI0514630 B8 BR PI0514630B8 BR PI0514630 A BRPI0514630 A BR PI0514630A BR PI0514630 A BRPI0514630 A BR PI0514630A BR PI0514630 B8 BRPI0514630 B8 BR PI0514630B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- triazolyl
- alpha
- compounds
- mercaptoacetanilide
- Prior art date
Links
- -1 s-triazolyl alpha-mercaptoacetanilide compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pens And Brushes (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Road Signs Or Road Markings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0520870A BRPI0520870B8 (pt) | 2004-08-25 | 2005-08-25 | compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60422004P | 2004-08-25 | 2004-08-25 | |
| US60421904P | 2004-08-25 | 2004-08-25 | |
| US60/604,219 | 2004-08-25 | ||
| US60/604,220 | 2004-08-25 | ||
| US68635105P | 2005-05-31 | 2005-05-31 | |
| US60/686,351 | 2005-05-31 | ||
| PCT/US2005/030259 WO2006026356A2 (en) | 2004-08-25 | 2005-08-25 | S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0514630A BRPI0514630A (pt) | 2008-06-17 |
| BRPI0514630B1 BRPI0514630B1 (pt) | 2020-09-15 |
| BRPI0514630B8 true BRPI0514630B8 (pt) | 2021-05-25 |
Family
ID=36000576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514630A BRPI0514630B8 (pt) | 2004-08-25 | 2005-08-25 | compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas |
| BRPI0520870A BRPI0520870B8 (pt) | 2004-08-25 | 2005-08-25 | compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0520870A BRPI0520870B8 (pt) | 2004-08-25 | 2005-08-25 | compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila |
Country Status (31)
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1789039B1 (en) | 2004-08-25 | 2012-01-11 | Ardea Biosciences, Inc. | S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase |
| WO2007050087A1 (en) * | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| ES2542153T3 (es) | 2007-05-30 | 2015-07-31 | F. Hoffmann-La Roche Ag | Inhibidores no nucleósidos de la transcriptasa inversa |
| WO2009030996A1 (en) * | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Triazole compounds as toll-like receptor (tlr) agonists |
| JP5099794B2 (ja) * | 2007-11-27 | 2012-12-19 | アルデア バイオサイエンシーズ インク． | 新規化合物、組成物、及び使用方法 |
| MX2011002450A (es) | 2008-09-04 | 2011-05-25 | Ardea Biosciences Inc | Compuestos, composiciones y métodos para utilizar los mismos para modular niveles de ácido úrico. |
| US8242154B2 (en) | 2008-09-04 | 2012-08-14 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
| US8173690B2 (en) * | 2008-09-04 | 2012-05-08 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
| EP2349258A1 (en) * | 2008-10-24 | 2011-08-03 | Ardea Biosciences, Inc. | Compositions comprising 4- (2- ( 5-br0m0-4- ( l-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triazol-3-ylthio) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| WO2010048592A1 (en) * | 2008-10-24 | 2010-04-29 | Ardea Biosciences, Inc. | Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| EP2432468A2 (en) | 2009-05-20 | 2012-03-28 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
| CN102040546B (zh) * | 2009-10-10 | 2014-10-15 | 台州市华南医化有限公司 | 一种4-环丙基-1-异硫氰基萘的制备方法及中间体4-环丙基-1-萘甲醛肟/卤化物 |
| EP2521716B1 (en) * | 2010-01-08 | 2015-12-30 | Ardea Biosciences, Inc. | Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
| EP3659601A1 (en) | 2010-03-30 | 2020-06-03 | Ardea Biosciences, Inc. | Treatment of gout |
| EP2582683B1 (en) | 2010-06-15 | 2018-03-21 | Ardea Biosciences, Inc. | Treatment of gout and hyperuricemia |
| AR081930A1 (es) | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | Compuestos de tioacetato |
| EP2582664A4 (en) | 2010-06-16 | 2014-07-09 | Ardea Biosciences Inc | PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE |
| CN101899013B (zh) * | 2010-07-12 | 2012-07-25 | 山东大学 | 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用 |
| CA2813555C (en) * | 2010-10-15 | 2014-11-25 | Ardea Biosciences, Inc. | Methods for treating hyperuricemia and related diseases |
| CA2817249C (en) | 2010-12-30 | 2015-02-10 | Ardea Biosciences, Inc. | Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof |
| AU2012332154B2 (en) | 2011-11-03 | 2016-11-17 | Ardea Biosciences, Inc. | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| AR091651A1 (es) * | 2012-07-03 | 2015-02-18 | Ardea Biosciences Inc | Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico |
| CN105263913B (zh) * | 2013-06-14 | 2017-12-15 | 广东东阳光药业有限公司 | 硫代1,2,4‑三唑衍生物及其制备方法 |
| CN103524440B (zh) * | 2013-10-15 | 2015-09-09 | 苏州鹏旭医药科技有限公司 | 痛风治疗药Lesinurad的制备方法及Lesinurad中间体 |
| AU2014351486C1 (en) * | 2013-11-22 | 2019-06-06 | Crystal Pharmatech Co., Ltd. | Crystalline forms of lesinurad and its sodium salt |
| CN104557748A (zh) * | 2014-01-25 | 2015-04-29 | 广东东阳光药业有限公司 | 硫代-1,2,4-三唑衍生物的新的固体形态 |
| CN105315218A (zh) * | 2014-07-17 | 2016-02-10 | 天津药物研究院 | 一种制备lesinurad中间体1-萘基三唑硫酮的方法 |
| CN104326993B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 一种硝基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104341363B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 一种硝基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104311498B (zh) * | 2014-10-27 | 2016-04-06 | 张远强 | 烷氧基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104341361B (zh) * | 2014-10-27 | 2017-01-11 | 张远强 | 一种腈基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104327000B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 苯基取代的三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104370842B (zh) * | 2014-10-27 | 2016-07-13 | 张远强 | 苯基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104370841B (zh) * | 2014-10-27 | 2016-07-13 | 张远强 | 三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104341362B (zh) * | 2014-10-27 | 2016-07-13 | 张远强 | 三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104326998B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 苯基取代的三氮唑丙二酸类化合物、其制备方法及用途 |
| EP3112334A1 (en) | 2015-06-29 | 2017-01-04 | DPx Fine Chemicals Austria GmbH & CoKG | Process for manufacturing 1-cyclopropyl-naphthalenes |
| CN104987311A (zh) * | 2015-06-30 | 2015-10-21 | 安徽万邦医药科技有限公司 | 一种[4-(4-环丙基萘-1-基)-5-硝基- 4h-[1,2,4]三唑-3-基硫烷基]-乙酸乙酯的制备方法及其中间体(5-硝基-4h-[1,2,4]三唑-3-基硫基)-乙酸乙酯 |
| CN105153056A (zh) * | 2015-07-01 | 2015-12-16 | 安徽万邦医药科技有限公司 | 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法 |
| CN105017168A (zh) * | 2015-07-01 | 2015-11-04 | 安徽万邦医药科技有限公司 | 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法 |
| WO2017036884A1 (en) | 2015-08-28 | 2017-03-09 | Sandoz Ag | A lesinurad, free form / lesinurad ethyl ester co-crystal |
| CN105566237B (zh) * | 2016-03-01 | 2018-05-18 | 山东大学 | 一种治疗痛风的三唑巯乙酸类化合物的制备方法 |
| JP7050009B2 (ja) * | 2016-06-17 | 2022-04-07 | メッドシャイン ディスカバリー インコーポレイテッド | ハロゲン化合物およびその軸性キラリティ異性体 |
| EP3281941B1 (en) | 2016-08-11 | 2019-07-24 | Zentiva K.S. | Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid |
| EP3372592A1 (en) | 2017-03-07 | 2018-09-12 | Zentiva, k.s. | Solid forms of lesinurad amine salts |
| US10351537B2 (en) * | 2017-03-10 | 2019-07-16 | Apotex Inc. | Processes for the preparation of lesinurad and intermediates thereof |
| EP3315494A1 (en) | 2017-04-19 | 2018-05-02 | Química Sintética, S.A. | Amorphous form of lesinurad and processes for its preparation |
| CN108947919B (zh) | 2017-05-17 | 2023-05-02 | 上海奥博生物医药股份有限公司 | 一种抗痛风药Lesinurad的新型制备方法及其关键中间体 |
| WO2019001325A1 (zh) * | 2017-06-28 | 2019-01-03 | 苏州科睿思制药有限公司 | 雷西纳得的晶型xv及其制备方法 |
| EP3498697A1 (en) | 2017-12-12 | 2019-06-19 | Química Sintética, S.A. | Novel salts and polymorphs of lesinurad |
| JP7728864B2 (ja) | 2021-05-28 | 2025-08-25 | 住友化学株式会社 | シクロアルキルブロミドの製造方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2009A (en) * | 1841-03-18 | Improvement in machines for boring war-rockets | ||
| US226186A (en) | 1880-04-06 | Car-coupling | ||
| US2008A (en) * | 1841-03-18 | Gas-lamp eok conducting gas pkom ah elevated buhner to one below it | ||
| US2006A (en) * | 1841-03-16 | Clamp for crimping leather | ||
| JPS5641637B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-11-26 | 1981-09-29 | ||
| US6832996B2 (en) | 1995-06-07 | 2004-12-21 | Arthrocare Corporation | Electrosurgical systems and methods for treating tissue |
| JPH07215940A (ja) | 1994-01-27 | 1995-08-15 | Torii Yakuhin Kk | 抗ウイルス活性を有する化合物 |
| JP2000510164A (ja) | 1997-02-14 | 2000-08-08 | バイエル・コーポレーシヨン | 選択的神経ペプチドｙ受容体アンタゴニストとしてのアミド誘導体 |
| US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
| JPH10243033A (ja) * | 1997-02-28 | 1998-09-11 | Oki Electric Ind Co Ltd | 復調装置 |
| DE69943247D1 (de) | 1998-03-27 | 2011-04-14 | Janssen Pharmaceutica Nv | HIV hemmende Pyrimidin Derivate |
| DK1129096T3 (da) | 1998-11-12 | 2003-09-15 | Neurocrine Biosciences Inc | CRF-receptorantagonister og fremgangsmåder, der er relateret dertil |
| WO2000037471A1 (en) | 1998-12-23 | 2000-06-29 | Neurogen Corporation | 2-amino-9-alkylpurines: gaba brain receptor ligands |
| IL143958A0 (en) * | 1998-12-25 | 2002-04-21 | Shionogi & Co | Heteroaromatic derivatives having an inhibitory activity against hiv integrase |
| US6593077B2 (en) | 1999-03-22 | 2003-07-15 | Special Materials Research And Technology, Inc. | Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate |
| KR100638954B1 (ko) | 2001-03-02 | 2006-10-25 | 스미스클라인 비참 코포레이션 | 역전사 효소 억제제로서의 벤조페논 |
| JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
| JP2005529923A (ja) | 2002-05-13 | 2005-10-06 | イーライ・リリー・アンド・カンパニー | 肥満および糖尿病の治療におけるメラニン凝集ホルモンアンタゴニストとして使用するための多環式化合物 |
| BR0313747A (pt) | 2002-08-23 | 2005-06-21 | Ribapharm Inc | Inibidores de transcriptase reversa de não-nucleosìdeo |
| US7642277B2 (en) * | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| CN102151270A (zh) | 2003-02-07 | 2011-08-17 | 詹森药业有限公司 | 预防hiv感染的嘧啶衍生物 |
| WO2005028479A2 (en) | 2003-09-25 | 2005-03-31 | Janssen Pharmaceutica N.V. | Hiv replication inhibiting purine derivatives |
| US20080031901A1 (en) * | 2004-09-24 | 2008-02-07 | Abbott Laboratories | Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| US7517998B2 (en) | 2004-06-01 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Non nucleoside reverse transcriptase inhibitors |
| WO2007050087A1 (en) | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| EP1789039B1 (en) | 2004-08-25 | 2012-01-11 | Ardea Biosciences, Inc. | S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase |
| JP5099794B2 (ja) | 2007-11-27 | 2012-12-19 | アルデア バイオサイエンシーズ インク． | 新規化合物、組成物、及び使用方法 |
| EP2349258A1 (en) | 2008-10-24 | 2011-08-03 | Ardea Biosciences, Inc. | Compositions comprising 4- (2- ( 5-br0m0-4- ( l-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triazol-3-ylthio) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| WO2010048592A1 (en) | 2008-10-24 | 2010-04-29 | Ardea Biosciences, Inc. | Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| TWM377707U (en) | 2009-09-16 | 2010-04-01 | Nat Energy Technology Co Ltd | Assembly of power supply |
-
2005
- 2005-08-25 EP EP05790722A patent/EP1789039B1/en not_active Expired - Lifetime
- 2005-08-25 US US11/661,079 patent/US7947721B2/en active Active
- 2005-08-25 NZ NZ553534A patent/NZ553534A/en not_active IP Right Cessation
- 2005-08-25 JP JP2007530127A patent/JP4952943B2/ja not_active Expired - Lifetime
- 2005-08-25 ME MEP-2013-18A patent/ME01512B/me unknown
- 2005-08-25 AU AU2005280130A patent/AU2005280130C9/en not_active Expired
- 2005-08-25 BR BRPI0514630A patent/BRPI0514630B8/pt active IP Right Grant
- 2005-08-25 ES ES05790722T patent/ES2380604T3/es not_active Expired - Lifetime
- 2005-08-25 CN CN200910205213.7A patent/CN101817793B/zh not_active Expired - Lifetime
- 2005-08-25 WO PCT/US2005/030259 patent/WO2006026356A2/en active Application Filing
- 2005-08-25 SG SG200905668-0A patent/SG155246A1/en unknown
- 2005-08-25 EP EP09170772A patent/EP2135608B8/en not_active Expired - Lifetime
- 2005-08-25 BR BRPI0520870A patent/BRPI0520870B8/pt active IP Right Grant
- 2005-08-25 CN CN2005800363729A patent/CN101083987B/zh not_active Expired - Lifetime
- 2005-08-25 ES ES09170772T patent/ES2374773T3/es not_active Expired - Lifetime
- 2005-08-25 PL PL09170772T patent/PL2135608T3/pl unknown
- 2005-08-25 AT AT05790722T patent/ATE540677T1/de active
- 2005-08-25 DK DK09170772.9T patent/DK2135608T3/da active
- 2005-08-25 EP EP12187096.8A patent/EP2609917A1/en not_active Withdrawn
- 2005-08-25 EP EP11184025A patent/EP2433633A1/en not_active Withdrawn
- 2005-08-25 EA EA200901186A patent/EA015846B1/ru not_active IP Right Cessation
- 2005-08-25 NZ NZ581376A patent/NZ581376A/en not_active IP Right Cessation
- 2005-08-25 RS RS20130029A patent/RS52632B/en unknown
- 2005-08-25 CA CA2578068A patent/CA2578068C/en not_active Expired - Lifetime
- 2005-08-25 SG SG2012083366A patent/SG185992A1/en unknown
- 2005-08-25 SI SI200531426T patent/SI2135608T1/sl unknown
- 2005-08-25 MX MX2007002236A patent/MX2007002236A/es active IP Right Grant
- 2005-08-25 KR KR1020077006746A patent/KR101241716B1/ko not_active Expired - Lifetime
- 2005-08-25 EA EA200700488A patent/EA014737B1/ru not_active IP Right Cessation
- 2005-08-25 PT PT09170772T patent/PT2135608E/pt unknown
- 2005-08-25 EP EP11177941A patent/EP2402011B1/en not_active Expired - Lifetime
- 2005-08-25 IN IN3762CHN2014 patent/IN2014CN03762A/en unknown
- 2005-08-25 AT AT09170772T patent/ATE528001T1/de active
-
2007
- 2007-02-22 IL IL181523A patent/IL181523A/en active IP Right Grant
- 2007-03-15 EC EC2007007322A patent/ECSP077322A/es unknown
-
2009
- 2009-09-23 AU AU2009217458A patent/AU2009217458B2/en not_active Expired
- 2009-10-15 IL IL201546A patent/IL201546A/en not_active IP Right Cessation
- 2009-11-13 US US12/618,604 patent/US20100069645A1/en not_active Abandoned
- 2009-12-08 US US12/633,638 patent/US8003681B2/en not_active Expired - Lifetime
-
2011
- 2011-04-06 US US13/081,398 patent/US8946273B2/en active Active
- 2011-06-30 US US13/174,538 patent/US8252828B2/en not_active Expired - Lifetime
-
2012
- 2012-01-05 JP JP2012000790A patent/JP5457472B2/ja not_active Expired - Lifetime
- 2012-01-11 CY CY20121100023T patent/CY1112221T1/el unknown
- 2012-04-15 IL IL219131A patent/IL219131A0/en unknown
- 2012-07-18 US US13/552,443 patent/US8481581B2/en not_active Expired - Lifetime
-
2013
- 2013-01-29 HR HRP20130075TT patent/HRP20130075T1/hr unknown
-
2014
- 2014-12-03 US US14/559,803 patent/US20150094284A1/en not_active Abandoned
-
2016
- 2016-07-26 LT LTPA2016024C patent/LTC2135608I2/lt unknown
- 2016-07-28 NL NL300825C patent/NL300825I2/nl unknown
- 2016-07-29 FR FR16C0031C patent/FR16C0031I2/fr active Active
- 2016-08-10 LU LU93169C patent/LU93169I2/fr unknown
- 2016-08-10 CY CY2016028C patent/CY2016028I2/el unknown
- 2016-08-17 HU HUS1600034C patent/HUS1600034I1/hu unknown
-
2017
- 2017-02-16 US US15/435,119 patent/US20180002296A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0514630B8 (pt) | compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas | |
| BR0309557A (pt) | Inibidores da transcriptase reversa não nucleosìdeos | |
| TR200201187T2 (tr) | Ters transkriptazın inhibitörleri olarak benzofenonlar | |
| SE0102315D0 (sv) | Compounds | |
| UY27127A1 (es) | Derivados de la urea como antagonistas de integrin alfa-4 | |
| ATE401076T1 (de) | Chinolinderivate als glucokinase liganden | |
| DE69608916D1 (de) | Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen | |
| ATE218581T1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
| UY25157A1 (es) | Composiciones farmacéuticas conteniendo atorvastatina y amlodipino | |
| PT824524E (pt) | Compostos de pirimidina-tioalquilo e alquileter substituidos em alfa como inibidores da transcriptase reversa viral | |
| DE60310767D1 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
| PA8579801A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
| GEP20084490B (en) | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof | |
| DE60315874D1 (de) | Substituierte dihydrophenanthridin-sulfonamide | |
| NO20044549L (no) | Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
| DK1992338T5 (da) | Farmaceutiske sammensætninger til oral administration af heparin eller derivater deraf | |
| BR0102377A (pt) | Inibidores de não-nucleosìdeo transcriptase reversa | |
| BR0314781A (pt) | Composição de polìmero e formas de dosagem compreendendo a mesma | |
| NO20044550L (no) | Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer | |
| DK1173176T3 (da) | Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas | |
| BRPI0412111A (pt) | poliorganossiloxanos | |
| ECSP045086A (es) | Composiciones farmaceuticas que contienen macrolidos | |
| DK1541553T3 (da) | Indolinforbindelse samt medicinsk anvendelse deraf | |
| ATE431153T1 (de) | Cycloglycane geeignet zur verhinderung der infektion von säugetierzellen | |
| TH41955A (th) | การใช้ควินอกซาบีนส์ในสารรวม 3 ชนิดกับตัวหยุดยั้งทรานส์คริปเตสผันกลับเป็นยารักษาโรคเอดส์หรือการติดเชื้อ hiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: ARDEA BIOSCIENCES, INC. (US) |
|
| B25G | Requested change of headquarter approved |
Owner name: ARDEA BIOSCIENCES, INC. (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/08/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |